0000950123-23-005337.txt : 20230515 0000950123-23-005337.hdr.sgml : 20230515 20230515161628 ACCESSION NUMBER: 0000950123-23-005337 CONFORMED SUBMISSION TYPE: 13F-NT PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230515 DATE AS OF CHANGE: 20230515 EFFECTIVENESS DATE: 20230515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bain Capital Life Sciences Fund II, L.P. CENTRAL INDEX KEY: 0001773187 IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-NT SEC ACT: 1934 Act SEC FILE NUMBER: 028-20814 FILM NUMBER: 23922625 BUSINESS ADDRESS: STREET 1: 200 CLARENDON STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6175162000 MAIL ADDRESS: STREET 1: 200 CLARENDON STREET CITY: BOSTON STATE: MA ZIP: 02116 13F-NT 1 primary_doc.xml X0202 13F-NT LIVE 0001773187 XXXXXXXX 03-31-2023 03-31-2023 false Bain Capital Life Sciences Fund II, L.P.

200 Clarendon Street Boston MA 02116

13F NOTICE 028-20814 28-18477 Bain Capital Life Sciences Investors, LLC 28-20816 Bain Capital Life Sciences Investors II, LLC Y The report on Form 13F for the period ended March 31, 2023 for Bain Capital Life Sciences Fund II, L.P. (the "Fund") is being filed by Bain Capital Life Sciences Investors, LLC, which is the manager of Bain Capital Life Sciences Investors II, LLC, which is the general partner of the Fund. Adam Koppel 617-516-2000 /s/ Adam Koppel Boston MA 05-15-2023